IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 31 filers reported holding IMMUCELL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,000 | +1.8% | 21,354 | 0.0% | 0.00% | – |
| Q2 2023 | $109,000 | -0.9% | 21,354 | 0.0% | 0.00% | – |
| Q1 2023 | $110,000 | -16.0% | 21,354 | 0.0% | 0.00% | – |
| Q4 2022 | $131,000 | -18.1% | 21,354 | 0.0% | 0.00% | – |
| Q3 2022 | $160,000 | +0.6% | 21,354 | +16.3% | 0.00% | – |
| Q2 2022 | $159,000 | -10.2% | 18,354 | 0.0% | 0.00% | – |
| Q1 2022 | $177,000 | +21.2% | 18,354 | +0.5% | 0.00% | – |
| Q4 2021 | $146,000 | -13.6% | 18,254 | 0.0% | 0.00% | – |
| Q3 2021 | $169,000 | +12.7% | 18,254 | +15.9% | 0.00% | – |
| Q2 2021 | $150,000 | -1.3% | 15,754 | 0.0% | 0.00% | – |
| Q1 2021 | $152,000 | +50.5% | 15,754 | -6.6% | 0.00% | – |
| Q4 2020 | $101,000 | +38.4% | 16,874 | +26.2% | 0.00% | – |
| Q3 2020 | $73,000 | +17.7% | 13,374 | 0.0% | 0.00% | – |
| Q2 2020 | $62,000 | +21.6% | 13,374 | 0.0% | 0.00% | – |
| Q1 2020 | $51,000 | -33.8% | 13,374 | -10.7% | 0.00% | – |
| Q4 2019 | $77,000 | – | 14,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |